In terms of animal survival, both VV treatment and PD-L1 blockade led to improvements in survival, but the combination of VV plus α-PD-L1 Ab led to the best overall survival in both colon cancer (Fig. 4c) and ovarian cancer (Fig. 4d). Here, CD274 is linked to ovarian carcinoma.